Ebola vaccine trial finds 'no red flags' - U.S. Senate testimony

NEW YORK (Reuters) - A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline has injected 10 healthy volunteers since Sept. 2, Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases told a U.S. Senate panel on Tuesday, and so far "no red flags" indicating serious adverse reactions have been found.

An additional 10 volunteers will receive the vaccine in coming days.

Limited time offer:
Just RM5 per month.

Monthly Plan

~~RM13.90/month~~
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Found a mistake in this article?

Report it to us.

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Email (optional)

Ebola vaccine trial finds 'no red flags' - U.S. Senate testimony

Limited time offer:
Just RM5 per month.

Monthly Plan

Annual Plan

1 month

Found a mistake in this article?

Ready for take-off at MATTA Fair Penang 2024

Next In World

Air Pollutant Index

Highest API Readings

Others Also Read

Thank you for downloading.

Ebola vaccine trial finds 'no red flags' - U.S. Senate testimony

Limited time offer: Just RM5 per month.

Monthly Plan

Annual Plan

1 month

Found a mistake in this article?

Ready for take-off at MATTA Fair Penang 2024

Next In World

Trending in News

Air Pollutant Index

Highest API Readings

Select State and Location to view the latest API reading

Others Also Read

Thank you for downloading.

Limited time offer:
Just RM5 per month.